[
  {
    "criterion": "Mentions CGRP inhibitors as a potential treatment option for migraines with aura",
    "axis": "completeness",
    "point": 8
  },
  {
    "criterion": "Provides an incorrect or misleading statement about the effectiveness of topiramate or propranolol",
    "axis": "accuracy",
    "point": -6
  },
  {
    "criterion": "Asks the user to clarify the duration of their migraines with aura",
    "axis": "context_awareness",
    "point": 5
  },
  {
    "criterion": "Suggests that the user should discontinue their current medication regimen",
    "axis": "instruction_following",
    "point": -8
  },
  {
    "criterion": "Explains the potential benefits and risks of CGRP inhibitors for migraines with aura",
    "axis": "communication_quality",
    "point": 9
  },
  {
    "criterion": "Does not provide any information about the potential side effects of CGRP inhibitors",
    "axis": "completeness",
    "point": -4
  },
  {
    "criterion": "States that MRI results are irrelevant to the diagnosis or treatment of migraines",
    "axis": "accuracy",
    "point": -8
  },
  {
    "criterion": "Provides a detailed explanation of the user's headache journal and its potential impact on treatment",
    "axis": "context_awareness",
    "point": 10
  },
  {
    "criterion": "Mentions the importance of consulting a healthcare professional before starting a new medication regimen",
    "axis": "completeness",
    "point": 8
  },
  {
    "criterion": "Provides an overly simplistic or generic response that does not take into account the user's specific situation",
    "axis": "communication_quality",
    "point": -5
  },
  {
    "criterion": "Falsely claims that topiramate and propranolol are ineffective for migraines with aura",
    "axis": "accuracy",
    "point": -9
  }
]